ADL
BNTX icon

Asset Dedication LLC’s BioNTech BNTX Stock Holding History

Asset Dedication LLC’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.44K Hold
37
– – ﹤0.01% 971
2026
Q1 		$3.29K Hold
37
– – ﹤0.01% 913
2025
Q4 		$3.52K Hold
37
– – ﹤0.01% 942
2025
Q3 		$3.65K Hold
37
– – ﹤0.01% 948
2025
Q2 		$3.94K Hold
37
– – ﹤0.01% 962
2025
Q1 		$3.37K Sell
37
-4
-10% -$448 ﹤0.01% 912
2024
Q4 		$4.67K Hold
41
– – ﹤0.01% 871
2024
Q3 		$4.87K Hold
41
– – ﹤0.01% 905
2024
Q2 		$3.29K Buy
+41
New +$3.75K ﹤0.01% 1008

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Asset Dedication LLC's BNTX Position: Q2 2026 in Review

Asset Dedication LLC held its BioNTech (BNTX) position steady in Q2 2026 at 37 shares worth $3.44K. The position accounts for ﹤0.01% of the portfolio, ranked #971.

Asset Dedication LLC first reported a position in BNTX in Q2 2024 and has held it in 9 quarters since. The position peaked at $4.87K in Q3 2024. 281 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Asset Dedication LLC held 37 shares of BioNTech worth $3.44K as of Q2 2026.
  • Asset Dedication LLC left its BioNTech share count unchanged in Q2 2026.
  • BioNTech made up ﹤0.01% of Asset Dedication LLC's portfolio in Q2 2026, its #971 holding.
  • Asset Dedication LLC first reported a position in BioNTech in Q2 2024 and has held it in 9 quarters since.
  • Asset Dedication LLC's BioNTech position peaked at $4.87K in Q3 2024.
  • 281 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Asset Dedication LLC's 13F filing for Q2 2026, filed 30 Jul 2026.